Novel genetic markers improve measures of atrial fibrillation risk prediction
Open Access
- 26 February 2013
- journal article
- research article
- Published by Oxford University Press (OUP) in European Heart Journal
- Vol. 34 (29), 2243-2251
- https://doi.org/10.1093/eurheartj/eht033
Abstract
Atrial fibrillation (AF) is associated with adverse outcome. Whether recently discovered genetic risk markers improve AF risk prediction is unknown. We derived and validated a novel AF risk prediction model from 32 possible predictors in the Women's Health Study (WHS), a cohort of 20 822 women without cardiovascular disease (CVD) at baseline followed prospectively for incident AF (median: 14.5 years). We then created a genetic risk score (GRS) comprised of 12 risk alleles in nine loci and assessed model performance in the validation cohort with and without the GRS. The newly derived WHS AF risk algorithm included terms for age, weight, height, systolic blood pressure, alcohol use, and smoking (current and past). In the validation cohort, this model was well calibrated with good discrimination [C-index (95% CI) = 0.718 (0.684–0.753)] and improved all reclassification indices when compared with age alone. The addition of the genetic score to the WHS AF risk algorithm model improved the C-index [0.741 (0.709–0.774); P = 0.001], the category-less net reclassification [0.490 (0.301–0.670); P < 0.0001], and the integrated discrimination improvement [0.00526 (0.0033–0.0076); P < 0.0001]. However, there was no improvement in net reclassification into 10-year risk categories of P = 0.33]. Among women without CVD, a simple risk prediction model utilizing readily available risk markers identified women at higher risk for AF. The addition of genetic information resulted in modest improvements in predictive accuracy that did not translate into improved reclassification into discrete AF risk categories.This publication has 29 references indexed in Scilit:
- Meta-analysis identifies six new susceptibility loci for atrial fibrillationNature Genetics, 2012
- Type 2 diabetes, glucose homeostasis and incident atrial fibrillation: the Atherosclerosis Risk in Communities studyHeart, 2011
- Risk of Death and Cardiovascular Events in Initially Healthy Women With New-Onset Atrial FibrillationJAMA, 2011
- A Clinical Risk Score for Atrial Fibrillation in a Biracial Prospective Cohort (from the Atherosclerosis Risk In Communities [ARIC] Study)The American Journal of Cardiology, 2011
- Association Between Familial Atrial Fibrillation and Risk of New-Onset Atrial FibrillationJAMA, 2010
- Validation of an Atrial Fibrillation Risk Algorithm in Whites and African AmericansJAMA Internal Medicine, 2010
- Extensions of net reclassification improvement calculations to measure usefulness of new biomarkersStatistics in Medicine, 2010
- A multimarker approach to assess the influence of inflammation on the incidence of atrial fibrillation in womenEuropean Heart Journal, 2010
- Relations of Biomarkers of Distinct Pathophysiological Pathways and Atrial Fibrillation Incidence in the CommunityCirculation, 2010
- Development of a risk score for atrial fibrillation (Framingham Heart Study): a community-based cohort studyThe Lancet, 2009